{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:23:39Z","timestamp":1770675819728,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010349","name":"Friedrich Wilhelm Frank og hustru Angelina Franks Mindelegat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.08.065","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T17:15:25Z","timestamp":1504372525000},"page":"5589-5596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors"],"prefix":"10.1016","volume":"35","author":[{"given":"Sigrun A.J.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mogens","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth M.","family":"Baggesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik C.","family":"Sch\u00f8nheyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.08.065_b0005","unstructured":"Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014; 89: 265\u201387."},{"key":"10.1016\/j.vaccine.2017.08.065_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2017.08.065_b0015","unstructured":"Glismann S, Muscat M, Bang H, Lewis H. Surveillance of Varicella and Herpes Zoster in Europe. EUVAC.NET hub, Department of Epidemiology, Statens Serum Institut (now part of the Vaccine Preventable Disease group, the European Centre for Disease Prevention and Control); 2011."},{"key":"10.1016\/j.vaccine.2017.08.065_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12879-016-1369-6","article-title":"Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality","volume":"16","author":"Schmidt","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyw213","article-title":"Data resource profile: the Danish national prescription registry","author":"Potteg\u00e5rd","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0035","unstructured":"Drugs, package sizes, and indications for use on the Danish drug market. n.d. http:\/\/pro.medicin.dk [accessed 29.04.14]."},{"key":"10.1016\/j.vaccine.2017.08.065_b0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/sti.79.6.456","article-title":"Epidemiology of recurrent genital herpes simplex virus types 1 and 2","volume":"79","author":"Solomon","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0050","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ije\/22.6.1189","article-title":"What does the odds ratio estimate in a case-control study?","volume":"22","author":"Pearce","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0055","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12879-015-1170-y","article-title":"Incidence of herpes zoster and associated events including stroke\u2013a population-based cohort study","volume":"15","author":"Sundstr\u00f6m","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0060","doi-asserted-by":"crossref","first-page":"g2911","DOI":"10.1136\/bmj.g2911","article-title":"Quantification of risk factors for herpes zoster: population based case-control study","volume":"348","author":"Forbes","year":"2014","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2017.08.065_b0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","article-title":"Incidence of herpes zoster and its complications in Germany, 2005\u20132009","volume":"70","author":"Hillebrand","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0070","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0075","unstructured":"Jean-Luc R, Hans-Peter Z. Herp\u00e8s zoster 1998\u20132001. Sentinella-Jahresbericht; 2017."},{"key":"10.1016\/j.vaccine.2017.08.065_b0080","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: Burden of disease in France","volume":"28","author":"Gonzalez Chiappe","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.065_b0085","first-page":"1","article-title":"Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a three-years population-based study","volume":"7","author":"Alicino","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.08.065_b0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2013.09.035","article-title":"Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005\u20132012","volume":"68","author":"Esteban-Vasallo","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2807\/esm.12.02.00687-en","article-title":"Surveillance of varicella and herpes zoster in Slovenia, 1996\u20132005","volume":"12","author":"Socan","year":"2007","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2017.08.065_b0100","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ebiom.2015.08.017","article-title":"Distribution of health effects and cost-effectiveness of varicella vaccination are shaped by the impact on herpes zoster","volume":"2","author":"van Lier","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2017.08.065_b0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","article-title":"Disease burden of herpes zoster in Sweden\u2013predominance in the elderly and in women - a register based study","volume":"13","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-11-173","article-title":"Herpes zoster in Germany: quantifying the burden of disease","volume":"11","author":"Ultsch","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0115","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.065_b0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jinf.2015.10.003","article-title":"Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability","volume":"72","author":"Esteban-Vasallo","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.20344\/amp.312","article-title":"Hospital admissions for herpes zoster in Portugal between 2000 and 2010","volume":"26","author":"Mesquita","year":"2013","journal-title":"Acta Med Port"},{"key":"10.1016\/j.vaccine.2017.08.065_b0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","article-title":"Different vaccination strategies in Spain and its impact on severe varicella and zoster","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.065_b0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0145","first-page":"839","article-title":"Naturhistoriske data fra et uselekteret herpes zoster-materiale","volume":"63","author":"Christensen","year":"1985","journal-title":"M\u00e5nedsskrift for Praktisk L\u00e6gegerning"},{"key":"10.1016\/j.vaccine.2017.08.065_b0150","first-page":"2194","article-title":"Herpes zoster incidence in persons above 50 years of age (article in Danish)","volume":"171","author":"\u00d8stergaard","year":"2009","journal-title":"Ugeskr Laeg"},{"key":"10.1016\/j.vaccine.2017.08.065_b0155","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of Herpes Zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.065_b0160","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.065_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw840","article-title":"Partner bereavement and risk of herpes zoster: results from two population-based case-control studies in Denmark and the United Kingdom","author":"Schmidt","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rdc.2016.09.010","article-title":"Incidence and prevention of herpes zoster reactivation in patients with autoimmune diseases","volume":"43","author":"Chakravarty","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2017.08.065_b0175","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0180","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0185","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2017.08.065_b0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijcp.12508","article-title":"Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study","volume":"69","author":"Tsai","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.vaccine.2017.08.065_b0195","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4161\/hv.28620","article-title":"Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)","volume":"10","author":"Esteban-Vasallo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.08.065_b0200","doi-asserted-by":"crossref","unstructured":"Ogunjimi B, Buntinx F, Bartholomeeusen S, Terpstra I, De haes I, Willem L, et al. Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. J Infect 2015; 70: 171\u20137. doi:10.1016\/j.jinf.2014.08.016.","DOI":"10.1016\/j.jinf.2014.08.016"},{"key":"10.1016\/j.vaccine.2017.08.065_b0205","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1017\/S0950268814003653","article-title":"Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study","volume":"143","author":"Liu","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.08.065_b0210","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2015.10.032","article-title":"Asthma as a risk factor for zoster in adults: a population-based case-control study","volume":"137","author":"Kwon","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.08.065_b0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02770903.2016.1211142","article-title":"Adult asthma is associated with an increased risk of herpes zoster: A population-based cohort study","volume":"54","author":"Peng","year":"2017","journal-title":"J Asthma"},{"key":"10.1016\/j.vaccine.2017.08.065_b0220","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1503\/cmaj.101137","article-title":"Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study","volume":"183","author":"Yang","year":"2011","journal-title":"Cmaj"},{"key":"10.1016\/j.vaccine.2017.08.065_b0225","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.mayocp.2012.05.021","article-title":"Chronic medical conditions as risk factors for herpes zoster","volume":"87","author":"Joesoef","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2017.08.065_b0230","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2012.03.018","article-title":"Risk of herpes zoster in CKD: a matched-cohort study based on administrative data","volume":"60","author":"Wu","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.vaccine.2017.08.065_b0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s15010-007-6347-x","article-title":"Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel","volume":"36","author":"Heymann","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2017.08.065_b0240","doi-asserted-by":"crossref","first-page":"e0155175","DOI":"10.1371\/journal.pone.0155175","article-title":"Association of Herpes Zoster and Type 1 Diabetes Mellitus","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.08.065_b0245","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s15010-014-0645-x","article-title":"Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997\u20132006","volume":"42","author":"Guignard","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2017.08.065_b0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2466-11-59","article-title":"Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study","volume":"11","author":"Ernst","year":"2011","journal-title":"BMC Pulm Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T23:13:29Z","timestamp":1656285209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17311635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":50,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17311635"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}